Brief: Race Oncology Posts FY Loss Attributable A$11.2 Million
26/08/2022 11:28
Aug 26 (Reuters) - Race Oncology Ltd RAC.AX :
* FY LOSS ATTRIBUTABLE A$11.2 MILLION VERSUS LOSS A$6.3
MILLION
Source text for Eikon: ID:nASX54qy7N
Further company coverage: RAC.AX
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220